#BEGIN_DRUGCARD DB04699

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
187997-16-6

# ChEBI_ID:
42639

# Chemical_Formula:
C4H6O2

# Chemical_IUPAC_Name:
oxolan-2-one

# Chemical_Structure:
Not Available

# Creation_Date:
2007-09-11 11:49:24 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
One of the FURANS with a carbonyl thereby forming a cyclic lactone.  It is an endogenous compound made from gamma-aminobutyrate and is the precursor of gamma-hydroxybutyrate.  It is also used as a pharmacological agent and solvent. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Solvents

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
4-Butyrolactone

# HET_ID:
GBL

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C4H6O2/c5-4-2-1-3-6-4/h1-3H2

# InChI_Key:
InChIKey=YEJRWHAVMIAJKC-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C01770

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4699

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
86.0892

# Molecular_Weight_Mono:
86.036779436

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.11

# Predicted_LogS:
0.44

# Predicted_Water_Solubility:
2.38e+02 g/l

# Primary_Accession_No:
DB04699

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
7302

# PubChem_Substance_ID:
46508619

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O=C1CCCO1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
1,4-Lactone
dihydrofuran-2(3h)-one

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:36 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
BA000016

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
nagJ

# Drug_Target_1_Gene_Sequence:
>3006 bp
CTATCTTGCAGTTCTTAAAGTTAGGCTTTCTTTACTTGAAACTTCCCCATTTGAATATTT
AGCTGCAATCTTAAAGTTATAGATTGTATGTCTATTTAACTTTTTAAATGTATAAGAAGT
TTCATCCTTGCCTATTTCAGCTACCTTTTTACCATCCTTATAAAGAATATATCCTTCTAA
GCCTTCTGTTGTTTCTGGTTCTGTCCAAGTTACAGTTACATTCTTTTTATTTATTTCTGA
TGCTTTAAAATCTCTTACTGGATTTACAACAATTTCTGGACTAGTTCCTTCTATTATATT
AACTGTTTTTTCAGTTCCTGCAATCTCATGAACTAACCCTTCTCCATCTCCAACTGATGA
ATTGGTTACGCTTAAATTGCTTCCTTCTGTTTTAGCTTCTGCTCTTAGGACAACCTTAGC
TAAAACTTCTTTAGCTGGCAATGGTTCTCCAGTTAAAGAACTTACAAGCACTCTAACCTT
TCCGTCTTCTATTTTCTTAGCATTTACAAACACTCCATCATCAGAAATTGCTTCTACATA
TTCAAAGGCATTTTCATCATAATTTAGTGTAAAATCATAAGCAAAAGCTTCTGCATTTAC
TAATTCGTCTATACCTACTCCAACTTCTATGTTTTCTCCAACTTGAACTTCCTCTAAAGC
TTCAAGAGATACACTTCCTGTTACCTCAGCAGCTTCTTTTAACTTTCCATGAACATTAAC
CTCTGCAGCAGTAGCAAATTTTCCTCTACCATTTGCTTGATCTGAAACGCTATCTGTAAC
ATCTAATCTTACATATTTAGCATCAACACTATCAAATTCTATAAATTTAATAGCTGCATT
ATCTTCTAAAGTTCCAGTTTTAACTTCTGTAAAGTTTTCTCCATCTAAACTAACAGATAC
TTTATACCCTGTTATTCTTCCATTTTTACTATCTTGTCTTGGAGCATATTTAACTTTATT
TATTTCATATACATTATCTAATTCTAAAGTTAAATGATGAGGACCTTCATGAGCAGGTGA
TGACCATTTACTATGCCAGAAAGTATTCATATCACCATCTGAAGCAAAGGAAGCTGGTGC
ATTTTCCCCTGAAGTCTCTTCAGATGAAGCTGTTATCTTTACTGTTCTTGGATTTATTAA
TGTTAAATCAAAACTTAAAGCTTCTTGTATAAATGATTGAGCAACCTTTTCAGATATAAC
TGCAAAGCTACTTAAGGCTGTATTTAATTTATTTTGTGCAATTTCTTTAGCACTTTCATA
AGCCTCTGTATCTTCATTTAATTGAGCTACAATCATATCTAATGAAGCCTTATCCCCTTG
AGCTAAAGTAATAAGTTCATCAAGTTGTCTTGAGCATTCTTCTAAAGCAACTTCAGGTAA
ATTTGCCTTTAGATTATTACAAGCTTCTTCCATTCTTGCAAACTCTCCATATAACTCTTC
TATAAGAGCACTTGCATCTTCTTTAGAAGATAACTTATTCCATAACTCATCCATTTTTGC
TCTAAGCTCTGGAGCGTCTTCTCTTCCTGATTTAGCCCAAGTTTTATTGTCCATTCTTGT
TGAATGGTTTGCAAATACCTTCATATCTTCTGCTAAATCACCATAAAGCATATCAATTGC
TCTATTCCAAGCCTTATCATAATCATAGTTATCCATATTCCAGCTATAGTCAGCAGCTGT
GTGTATTGATATTTTTGAAAGCTCAGCATGCTCCATTGGATTTACAGTAAAGAAATCTAC
ATATTGATTTAATCCTTTATCTAATCCATGCATTGGTCCTAAGGCAAGCTTACCTTTAAA
ATAATCTGTTACTGGATAATTCCACCATACTGCCATATTTCTATTGTATATTCCACTTAT
AAGTTGTGCATCACTTAAAGGAATTTCATTTGTAACAACTCCAGGACCAGTCCACATAAC
TTCTATACTAGGATCAACAGTTTCTGCAAAAATTCTAGTATAAGTTCTAGGTTGTCCATT
ACTTACCATAGCTCCAGTATCATACTCTGTTGGGACTGTTATTAATGGTTTTACATCTCC
CTTAGCCTTTACAAATTCTTCATTAAATCTATTTAAAACTTGAGCATGTTTAGCTGCACT
CTTATCTTGAATATCATCCCAATAGATTGCAAAACTTCTTACACCCATGTCATATAAAGA
TTCTGCTTTAGCTATTAAATGATTAAAATCTTCTTCTCCTGCTTCTCCATCAAATCTTAT
ATCTATTCCTGGAGAAATACCGAAAACAAAATCAACCTTATTTTCAGCAGAAGCATCTAT
AAGTTCTTGCATTCTTTGCATTTCATTTTCTGGATATGGCTCTCTCCATTTTTCTCTGTG
ATATGGATCATCTTTAGGAGCATAAATATATGTGTTTAATTTATTTTCTCCATAAAATTT
AATCTGATCTAATCTATCTTTATGTGTCCAAGGAGTTCCATAAAAACCTTCTACAATACC
CCTAGCACTAACTGTTGGATAATCAGTTATATTCACTTCTGGTATATTAGATTCCTTAAC
TAATTGCTTAAATGTTTGAACTCCATAGAAAGTTCCATCTCCATCTTTACCTTCAATAGC
TATTTTCCCATCATTTGAAACTAAAGCATATCCCTCTTCTTTTAAATTTTCTGCTGTAGT
TCCATTTAAAGCTTCATCTAACTCAGGAATATCATCATCAACCTCACCTATTATAAGGGT
AGTTGAATTTGGATCATTTTCACTATTTATTTCTATGTTGTTTGCAGTTAAAAATTCCCT
TAAAGCATTTACTGCATTCTCATCTGCCTCTTCCTCACCAACTAAATTTATAGAAGAAGT
TATCTTAAATCCATCTCCTACAACCTCTAAATTTTCTGGTGTTGGATTTAAATTTGGAAC
TAAAACCTGGTTTTCTTCCCCAGTTTTAGGTCCTACAGCTCTTACAGTAGTAGTTATTAA
GCCATTTGCAATAAACATACAAGCAAACGCTGAAGTTAAAAGTCTTTTAAGCATTTTTCT
TTTCAT

# Drug_Target_1_General_Function:
Involved in carbohydrate binding

# Drug_Target_1_General_References:
11792842	Shimizu T, Ohtani K, Hirakawa H, Ohshima K, Yamashita A, Shiba T, Ogasawara N, Hattori M, Kuhara S, Hayashi H: Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater. Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):996-1001. Epub 2002 Jan 15.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
5745

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
111110

# Drug_Target_1_Name:
O-GlcNAcase nagJ

# Drug_Target_1_Number_of_Residues:
1001

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00041	fn3
PF00754	F5_F8_type_C
PF07555	Hyaluronidase_2

# Drug_Target_1_Protein_Sequence:
>O-GlcNAcase nagJ
MKRKMLKRLLTSAFACMFIANGLITTTVRAVGPKTGEENQVLVPNLNPTPENLEVVGDGF
KITSSINLVGEEEADENAVNALREFLTANNIEINSENDPNSTTLIIGEVDDDIPELDEAL
NGTTAENLKEEGYALVSNDGKIAIEGKDGDGTFYGVQTFKQLVKESNIPEVNITDYPTVS
ARGIVEGFYGTPWTHKDRLDQIKFYGENKLNTYIYAPKDDPYHREKWREPYPENEMQRMQ
ELIDASAENKVDFVFGISPGIDIRFDGEAGEEDFNHLIAKAESLYDMGVRSFAIYWDDIQ
DKSAAKHAQVLNRFNEEFVKAKGDVKPLITVPTEYDTGAMVSNGQPRTYTRIFAETVDPS
IEVMWTGPGVVTNEIPLSDAQLISGIYNRNMAVWWNYPVTDYFKGKLALGPMHGLDKGLN
QYVDFFTVNPMEHAELSKISIHTAADYSWNMDNYDYDKAWNRAIDMLYGDLAEDMKVFAN
HSTRMDNKTWAKSGREDAPELRAKMDELWNKLSSKEDASALIEELYGEFARMEEACNNLK
ANLPEVALEECSRQLDELITLAQGDKASLDMIVAQLNEDTEAYESAKEIAQNKLNTALSS
FAVISEKVAQSFIQEALSFDLTLINPRTVKITASSEETSGENAPASFASDGDMNTFWHSK
WSSPAHEGPHHLTLELDNVYEINKVKYAPRQDSKNGRITGYKVSVSLDGENFTEVKTGTL
EDNAAIKFIEFDSVDAKYVRLDVTDSVSDQANGRGKFATAAEVNVHGKLKEAAEVTGSVS
LEALEEVQVGENIEVGVGIDELVNAEAFAYDFTLNYDENAFEYVEAISDDGVFVNAKKIE
DGKVRVLVSSLTGEPLPAKEVLAKVVLRAEAKTEGSNLSVTNSSVGDGEGLVHEIAGTEK
TVNIIEGTSPEIVVNPVRDFKASEINKKNVTVTWTEPETTEGLEGYILYKDGKKVAEIGK
DETSYTFKKLNRHTIYNFKIAAKYSNGEVSSKESLTLRTAR

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-30

# Drug_Target_1_Specific_Function:
Biological function unknown. Capable of hydrolyzing the glycosidic link of O-GlcNAcylated proteins (By similarity)

# Drug_Target_1_SwissProt_ID:
Q8XL08

# Drug_Target_1_SwissProt_Name:
OGA_CLOPE

# Drug_Target_1_Synonyms:
Beta-N-acetylhexosaminidase
Beta-hexosaminidase
EC 3.2.1.52
GH84
Hexosaminidase B
N- acetyl-beta-glucosaminidase
O-GlcNAcase nagJ precursor

# Drug_Target_1_Theoretical_pI:
4.36

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04699
